{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:37:00Z","timestamp":1793795820978,"version":"4.6.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Edwards Lifesciences Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p\/>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>The population of candidates to surgical aortic valve replacement (SAVR) is evolving. The Perimount Magna Ease\u00a9 bioprosthesis has been introduced relatively recently in the practice. We aimed at evaluating its long-term results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>This article describes a single-centre cohort of 1016 consecutive SAVRs with the Magna Ease\u00a9 valve (2008\u20132014), consisting of an all-comers population. We performed a prospective collection of in-hospital data, systematic clinical and echocardiographic follow-up. Valve-related events were as follows: structural valve deterioration (SVD; according to modified definition criteria), nonstructural valve dysfunction, patient\u2013prosthesis mismatch (PPM).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Age at SAVR was 73.4\u2009\u00b1\u20099.5\u2009years; calcified aortic stenosis was the indication to surgery in 59.6%. A total of 974 patients entered the follow-up; 564 were alive at the last follow-up (median duration: 9.8\u2009years) (up to 13.4\u2009years). New York Heart Association class was I or II in 92.1%. Overall survival at 10\u2009years was 56.8 \u00b1 1.8%. Freedom from SVD at 10 was 96.5 \u00b1 0.8% (Kaplan\u2013Meier) and 97.4 \u00b1 0.6% (competing risks) (28 SVD events after 6.9 \u00b1 3.3 years). There were 15 reinterventions for SVD (redo-SAVR and Transcatheter Aortic Valve Implantation (TAVI)); 10-year freedom from reintervention was 97.8 \u00b1 0.6%. Moderate and severe PPM occurred in 26.8% and 5.4%, respectively, without association with late mortality (P\u2009=\u20090.12 for moderate and P\u2009=\u20090.70 for severe PPM). Freedom from valve-related mortality was 97.8 \u00b1 0.5% at 10\u2009years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>In this follow-up of the Magna Ease bioprosthesis for SAVR, data indicate good late outcomes (30-day outcomes are excluded). Continued follow-up is required to further support its use in patients with life expectancy &amp;gt;10\u201312\u2009years.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezad351","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T03:18:18Z","timestamp":1700882298000},"source":"Crossref","is-referenced-by-count":6,"title":["Late clinical and echocardiographic results with the Magna Ease\u00a9 pericardial aortic bioprosthesis"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-6644","authenticated-orcid":false,"given":"Amedeo","family":"Anselmi","sequence":"first","affiliation":[{"name":"Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital , Rennes, France"},{"name":"Univ Rennes, CHU Rennes, Inserm, LTSI\u2014UMR 1099 , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Aymami","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital , Rennes, France"},{"name":"Univ Rennes, CHU Rennes, Inserm, LTSI\u2014UMR 1099 , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9527-8958","authenticated-orcid":false,"given":"Jacques","family":"Tomasi","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital , Rennes, France"},{"name":"Univ Rennes, CHU Rennes, Inserm, LTSI\u2014UMR 1099 , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"D\u2019Alessandro","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Langanay","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Corbineau","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital , Rennes, France"},{"name":"Univ Rennes, CHU Rennes, Inserm, LTSI\u2014UMR 1099 , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mancini","sequence":"additional","affiliation":[{"name":"Aix-Marseille Univ, Inserm, IRD, ISSPAM, APHM, Biostatistics Dept, UMR1252 SESSTIM Research Unit , Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Flecher","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital , Rennes, France"},{"name":"Univ Rennes, CHU Rennes, Inserm, LTSI\u2014UMR 1099 , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Verhoye","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital , Rennes, France"},{"name":"Univ Rennes, CHU Rennes, Inserm, LTSI\u2014UMR 1099 , Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"2024021117592534100_ezad351-B1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"60","author":"Vahanian","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024021117592534100_ezad351-B2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0038-1660517","article-title":"Hemodynamic results and mid-term follow-up of 850 19 to 23\u2009mm Perimount Magna Ease valves","volume":"67","author":"Anselmi","year":"2019","journal-title":"Thorac Cardiovasc Surg"},{"key":"2024021117592534100_ezad351-B3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.athoracsur.2019.12.071","article-title":"Trifecta versus perimount Magna Ease aortic valve prostheses","volume":"110","author":"Biancari","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"2024021117592534100_ezad351-B4","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jtcvs.2017.05.103","article-title":"Long-term follow-up of bioprosthetic aortic valve replacement in patients aged \u226460 years","volume":"154","author":"Anselmi","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024021117592534100_ezad351-B5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jtcvs.2007.12.002","article-title":"Guidelines for reporting mortality and morbidity after cardiac valve interventions","volume":"135","author":"Akins","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024021117592534100_ezad351-B6","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","article-title":"Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"77","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024021117592534100_ezad351-B7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2022.06.002","article-title":"Standardized definitions for bioprosthetic valve dysfunction following aortic or mitral valve replacement: JACC state-of-the-art review","volume":"80","author":"Pibarot","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024021117592534100_ezad351-B8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.030729","article-title":"Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves","volume":"137","author":"Dvir","year":"2018","journal-title":"Circulation"},{"key":"2024021117592534100_ezad351-B9","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J"},{"key":"2024021117592534100_ezad351-B10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.CIR.0000085167.67105.32","article-title":"Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement","volume":"108","author":"Blais","year":"2003","journal-title":"Circulation"},{"key":"2024021117592534100_ezad351-B11","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/ejcts\/ezv384","article-title":"Very long-term outcomes of the Carpentier-Edwards Perimount aortic valve in patients aged 50-65 years","volume":"49","author":"Bourguignon","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024021117592534100_ezad351-B12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/icvts\/ivab016","article-title":"Magna Ease bioprosthetic aortic valve: mid-term haemodynamic outcomes in 1126 patients","volume":"32","author":"Thorp","year":"2021","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2024021117592534100_ezad351-B13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.xjon.2022.05.008","article-title":"Durability of a bovine pericardial aortic bioprosthesis based on Valve Academic Research Consortium-3 echocardiographic criteria","volume":"11","author":"Kermen","year":"2022","journal-title":"JTCVS Open"},{"key":"2024021117592534100_ezad351-B14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13019-020-01248-2","article-title":"Mid-term follow-up after aortic valve replacement with the Carpentier Edwards Magna Ease prosthesis","volume":"15","author":"Rajab","year":"2020","journal-title":"J Cardiothorac Surg"},{"key":"2024021117592534100_ezad351-B15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/icvts\/ivaa236","article-title":"Structural valve deterioration after aortic valve replacement with the Trifecta valve","volume":"32","author":"Werner","year":"2021","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2024021117592534100_ezad351-B16","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.114.010400","article-title":"Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients","volume":"130","author":"S\u00e9nage","year":"2014","journal-title":"Circulation"},{"key":"2024021117592534100_ezad351-B17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jtcvs.2013.07.005","article-title":"Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic position","volume":"147","author":"Anselmi","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024021117592534100_ezad351-B18","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/ejcts\/ezv383","article-title":"Porcine xenograft for aortic, mitral and double valve replacement: long-term results of 2544 consecutive patients","volume":"49","author":"Lehmann","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024021117592534100_ezad351-B19","doi-asserted-by":"crossref","first-page":"e220962","DOI":"10.1001\/jamanetworkopen.2022.0962","article-title":"Comparison of long-term performance of bioprosthetic aortic valves in Sweden From 2003 to 2018","volume":"5","author":"Persson","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024021117592534100_ezad351-B20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/ejcts\/ezt245","article-title":"Indexed effective orifice area is a significant predictor of higher mid- and long-term mortality rates following aortic valve replacement in patients with prosthesis-patient mismatch","volume":"45","author":"Chen","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024021117592534100_ezad351-B21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jacc.2008.09.022","article-title":"Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction","volume":"53","author":"Mohty","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2024021117592534100_ezad351-B22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ejcts\/ezaa263","article-title":"Essential information on surgical heart valve characteristics for optimal valve prosthesis selection: expert consensus document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task Force","volume":"59","author":"Durko","year":"2021","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezad351\/53793083\/ezad351.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/65\/2\/ezad351\/56660108\/ezad351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/65\/2\/ezad351\/56660108\/ezad351.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T17:59:43Z","timestamp":1707674383000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezad351\/7450116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezad351","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,1]]},"published":{"date-parts":[[2023,11,24]]},"article-number":"ezad351"}}